Study Stopped
Too many barriers to enrolling well going forward
Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and Surgery
1 other identifier
interventional
10
1 country
1
Brief Summary
This is a pilot study with a feasibility lead-in evaluating the use of multimodal cancer rehabilitation in patients planning to undergo radiotherapy and surgical resection for extremity or superficial trunk soft tissue sarcoma (STS). At enrollment, patients will be assigned to either a pre-operative radiation or post-operative radiation cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedStudy Start
First participant enrolled
October 31, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2022
CompletedApril 12, 2022
April 1, 2022
1.8 years
April 10, 2019
April 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of prescribed dietary and physical therapy visits completed during the cancer rehabilitation protocol
* This will be quantified as the proportion of prescribed visits within the prehabilitation protocol that are attended by the patient. If a patient participates in any portion of a prescribed visit, it will be counted as attended. * Physical therapy visits are optional from 6 months-24 months
Through 3 month follow-up
Secondary Outcomes (10)
Rate of acute treatment-related grade 2 or higher toxicity attributed to the therapy
From baseline through 24 month follow-up
Quality of life as measured by the PROMIS Global total score
Change from baseline through 24 month follow-up
Quality of life as measured by the TESS
Change from baseline through 24 month follow-up
Patient cardiovascular capacity as measured by the 6-minute walk test
Change from baseline through 3 month follow-up
Patient general physical health status as measured by 30-second sit to stand test
Change from baseline through 3 month follow-up
- +5 more secondary outcomes
Study Arms (2)
Pre-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological Counsel
EXPERIMENTAL* Patients must be treated using daily image-guided radiotherapy * Dietary counseling at baseline * Exercise intervention throughout cancer rehabilitation protocol * Psychological screening with counselling services as needed - nurse will administer the NCCN distress thermometer and refer the patient to applicable psychological counselling
Post-Operative Radiotherapy: Dietary Counseling/Exercise/Psychological Counsel
EXPERIMENTAL* Patients must be treated using daily image-guided radiotherapy * Dietary counseling at baseline * Exercise intervention throughout cancer rehabilitation protocol * Psychological screening with counselling services as needed - nurse will administer the NCCN distress thermometer and refer the patient to applicable psychological counselling
Interventions
-The exercise part will consist of an evaluation and treatment as prescribed by a physical therapist including aerobic \& dynamic stretching warm-up, strength training, balance training, and flexibility training. Will also include a home exercise program (HEP). Physical therapists will have specialized training in cancer rehabilitation obtained through the ReVital certification process.
-The protocols include instructions for patient care from the time of pre-surgical admission to discharge, including directives regarding diet, labs, IV fluids, pain management, prophylactic medications, management of indwelling catheters and drains, and activity.
-The psychological screening will be completed by the Radiation Oncology nurse at the consult visit
-Patients will have a baseline nutrition counseling visit with a Registered Dietician. This may include a nutrition assessment and nutrition counseling to set priorities, establish goals, and create an individualized plan
Eligibility Criteria
You may qualify if:
- Histologically or cytologically confirmed soft tissue sarcoma of the extremity, or superficial trunk (abdomen or chest)
- Planning to receive radiotherapy and surgical resection
- At least 16 years of age.
- ECOG performance status ≤ 3
- Able to complete the cancer rehabilitation protocol safely, as determined by a treating physician.
- Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
You may not qualify if:
- Patients deemed ineligible for curative therapy by the treating medical oncologist, radiation oncologist, or surgeon.
- Patients with deep retroperitoneal or abdominal STS
- Patients who have received prior radiotherapy and, based on the treating radiation oncologist's opinion, may not safely be treated with protocol neoadjuvant radiotherapy.
- Currently receiving any investigational agents.
- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, or cardiac arrhythmia.
- Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test prior to starting radiotherapy.
- HIV-positive patients whose CD4+ T-cell count is \< 350 cells/mcL.
- Receiving concurrent chemoradiation therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Spraker, M.D., Ph.D.
Washington University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2019
First Posted
April 16, 2019
Study Start
October 31, 2019
Primary Completion
August 17, 2021
Study Completion
March 18, 2022
Last Updated
April 12, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share